TMDX TransMedics Group shares slide 7 as EPS miss overshadows robust 37 revenue growth CNH Ind CNH Management Strategy Q4 2025 Better Than Expected INBX Inhibrx Biosciences Inc reports narrow Q4 2025 EPS beat shares rise 616 percent on upbeat investor sentiment The hidden strength in Virtus NCZ most investors miss Momentum Building 20260508